Table 4.
Prevalence of sex across albumin quotient (QAlb) quartiles
| Q1 (QAlb < 4.06) | Q2 (4.06 < QAlb < 5.57) | Q3 (5.58 < QAlb < 8.97) | Q4 (QAlb > 8.98) | p | |
|---|---|---|---|---|---|
| All (n = 1209) | |||||
| Female: n (%) | 244 (81.3) | 194 (63.6) | 158 (52.3) | 122 (40.4) | <0.0001 |
| Male: n (%) | 56 (18.7) | 11 (36.4) | 144 (47.7) | 180 (59.6) | |
| MS (n = 297) | |||||
| Female: n (%) | 101 (82.8) | 58 (67.4) | 35 (53.8) | 10 (41.7) | <0.0001 |
| Male: n (%) | 21 (17.2) | 28 (32.6) | 30 (46.2) | 14 (58.3) | |
| OIND (n = 281) | |||||
| Female: n (%) | 23 (67.7) | 25 (51.0) | 31 (47.7) | 53 (39.8) | 0.0309 |
| Male: n (%) | 11 (32.4) | 24 (49.0) | 34 (52.3) | 80 (60.2) | |
| NIND (n = 297) | |||||
| Female: n (%) | 43 (71.7) | 47 (50.0) | 37 (44.6) | 19 (31.7) | 0.0002 |
| Male: n (%) | 17 (28.3) | 47 (50.0) | 46 (55.4) | 41 (68.3) | |
| UNK (n = 334) | |||||
| Female: n (%) | 77 (91.7) | 64 (84.2) | 55 (61.8) | 40 (47.1) | <0.0001 |
| Male: n (%) | 7 (8.3) | 12 (15.8) | 34 (38.2) | 45 (52.9) | |
| Age 16–40 (n = 465) | |||||
| Female: n (%) | 139 (84.2) | 92(64.3) | 58 (57.4) | 14 (25.0) | <0.0001 |
| Male: n (%) | 26 (15.8) | 51 (35.7) | 43 (42.6) | 42 (75.0) | |
| Age 41–60 (n = 435) | |||||
| Female: n (%) | 83 (78.3) | 63 (64.9) | 57 (51.4) | 53 (43.8) | <0.0001 |
| Male: n (%) | 23 (21.7) | 34 (35.1) | 54 (48.6) | 68 (56.2) | |
| Age > 60 (n = 309) | |||||
| Female: n (%) | 22 (75.9) | 39 (60.0) | 43 (47.8) | 55 (44.0) | 0.0071 |
| Male: n (%) | 7 (24.1) | 26 (40.0) | 47 (52.2) | 70 (56.0) | |
Chi square test was used for all comparisons
ALL patient groups analysed as a whole, MS multiple sclerosis, NIND non-inflammatory neurological diseases, OIND other inflammatory neurological diseases, UNK unknown-neurological diagnosis